Glr Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.32 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.32 Cr
as on 24-10-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 24-10-2024
- Revenue 94.00%
(FY 2023)
- Profit -14.77%
(FY 2023)
- Ebitda 19.54%
(FY 2023)
- Net Worth 15.51%
(FY 2023)
- Total Assets 128.07%
(FY 2023)
About Glr Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.32 Cr and a paid-up capital of Rs 1.32 Cr.
The company currently has active open charges totaling ₹3.50 M.
Sivasubramanian Murugan and Tirukalukundram Subramanyan serve as directors at the Company.
- CIN/LLPIN
U73200TN2010PTC074873
- Company No.
074873
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2010
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Glr Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasubramanian Murugan  | Managing Director | 11-Mar-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tirukalukundram Subramanyan | Director | 11-Mar-2010 | Current |
Financial Performance of Glr Laboratories.
Glr Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 94% increase. The company also saw a substantial fall in profitability, with a 14.77% decrease in profit. The company's net worth Soared by an impressive increase of 15.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glr Laboratories?
In 2023, Glr Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mdr Laboratories Private LimitedActive 1 year 1 monthSivasubramanian Murugan and Tirukalukundram Subramanyan are mutual person
- Pma Analytical Private LimitedActive 2 years 5 months
Sivasubramanian Murugan and Tirukalukundram Subramanyan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Mar 2023 | ₹3.50 M | Open |
How Many Employees Work at Glr Laboratories?
Glr Laboratories has a workforce of 144 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glr Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glr Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
